BBC Among Health Care ETFs
End-of-day Nov 19, 2026 · 32 Health care ETFs by 1Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | 0.0% | −7.8% | −6.2% | −27.0% | +3.1% | +19.8% | +122.6% | −9.8% | +105.1% | +56.0% |
| Peer average | −1.5% | −5.1% | −2.8% | −5.1% | +15.0% | +19.1% | +61.3% | +21.3% | +153.6% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$24 of every $1,000 in BBC is Kodiak
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | KODKodiak Sciences | Healthcare | 2.40% | $240.42 | 7,839 | $767K |
| 2 | XNCRXencor | Healthcare | 2.33% | $233.48 | 22K | $745K |
| 3 | TRAXFirst Tracks Biotherapeutics | Healthcare | 2.11% | $211.18 | 15K | $674K |
| 4 | SLSSELLAS Life Sciences Group | Healthcare | 1.92% | $191.91 | 34K | $612K |
| 5 | REPLReplimune Group | Healthcare | 1.87% | $186.75 | 30K | $596K |
| 6 | ABCLAbCellera Biologics | Healthcare | 1.76% | $176.04 | 51K | $561K |
| 7 | VRDNViridian Therapeutics | Healthcare | 1.54% | $154.22 | 16K | $492K |
| 8 | AMLXAmylyx Pharmaceuticals | Healthcare | 1.53% | $152.73 | 18K | $487K |
| 9 | SGPSpyGlass Pharma | Healthcare | 1.35% | $134.74 | 14K | $430K |
| 10 | MBXMBX Biosciences | Healthcare | 1.26% | $125.95 | 7,519 | $402K |
| 11 | LBRXLB Pharmaceuticals | Healthcare | 1.18% | $118.00 | 9,394 | $376K |
| 12 | KYMRKymera Therapeutics | Healthcare | 1.18% | $117.63 | 3,097 | $375K |
| 13 | PRMEPrime Medicine | Healthcare | 1.15% | $115.23 | 96K | $367K |
| 14 | ORKAOruka Therapeutics | Healthcare | 1.15% | $114.68 | 3,820 | $366K |
| 15 | PVLAPalvella Therapeutics | Healthcare | 1.13% | $112.65 | 2,451 | $359K |
of the $110B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | KOD | Kodiak Sciences | 2.40% |
| 2 | XNCR | Xencor | 2.33% |
| 3 | TRAX | First Tracks Biotherapeutics | 2.11% |
| 4 | SLS | SELLAS Life Sciences Group | 1.92% |
| 5 | REPL | Replimune Group | 1.87% |
| 6 | ABCL | AbCellera Biologics | 1.76% |
| 7 | VRDN | Viridian Therapeutics | 1.54% |
| 8 | AMLX | Amylyx Pharmaceuticals | 1.53% |
| 9 | SGP | SpyGlass Pharma | 1.35% |
| 10 | MBX | MBX Biosciences | 1.26% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 22, 2025 | Dec 29, 2025 | $0.66 |
| Dec 20, 2024 | Dec 27, 2024 | $0.24 |
| Dec 20, 2023 | Dec 29, 2023 | $0.0823 |
| Dec 20, 2017 | Dec 27, 2017 | $0.30 |
| Dec 21, 2015 | Dec 29, 2015 | $0.15 |